Clinical Trial

Muscular Synergies and Behavioral Adaptations of Gait in Pain Anticipation (SYAMAPP)

Study acronym: SYAMAPP
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether the anticipation of pain influences gait control and psychophysiological responses in healthy individuals. Participants will receive a neutral cream described either as potentially painful (experimental group) or inert (control group), and their behavioral and physiological adaptations will be measured during walking tasks.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-14; most recent amendment 2026-06-08.
Status change: Not Yet Recruiting → Recruiting 2026-06-08
Trial Details
NCT Number NCT06929559
Lead Sponsor Universite de Picardie Jules Verne
Conditions Nocebo Effect, Pain Anticipation
Enrollment 34 participants
Start Date 2026-01-01
Primary Completion 2026-10-30 (estimated)
Study Completion 2028-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-11